From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Store the lyophilised solid desiccated at -20C, protected from light
When you partake in a medically supervised peptide protocol, your provider will use your symptoms, functional milestones, and periodic assessments to see whether the treatment appears to be supporting your recovery goals
It is structurally designed to interact with metabolic enzyme pathways and has become a subject of interest in metabolic and mitochondrial research fields
doi: 10.1080/00480169.1998.36089